Literature DB >> 4997495

[Comparative study of portocaval encephalopathy treatment with lactulose, lactobacilli and antibiotics].

M Imler, D Kurtz, R Bockel, J Stahl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4997495

Source DB:  PubMed          Journal:  Therapeutique        ISSN: 0040-5922


× No keyword cloud information.
  5 in total

Review 1.  Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.

Authors:  G S Avery; E F Davies; R N Brogden
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Interactions of lactulose and neomycin.

Authors:  H O Conn
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.

Authors:  F Orlandi; U Freddara; M T Candelaresi; A Morettini; G R Corazza; A Di Simone; G Dobrilla; G Cavallini
Journal:  Dig Dis Sci       Date:  1981-06       Impact factor: 3.199

Review 4.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 5.  Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy.

Authors:  Liliana Rivera-Espinosa; Esaú Floriano-Sánchez; José Pedraza-Chaverrí; Elvia Coballase-Urrutia; Aristides Iii Sampieri; Daniel Ortega-Cuellar; Noemí Cárdenas-Rodríguez; Liliana Carmona-Aparicio
Journal:  Int J Mol Sci       Date:  2013-08-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.